Recently, medical laboratory services provider Lancet Laboratories, with a presence in Kenya and 14 other African countries, announced a joint venture (JV) with European multinational Cerba HealthCare that will now have a majority shareholding. Financial Standard sought more insights into the deal from Dr Ahmed Kalebi, the founding partner and Group CEO Lancet Group of Labs.
For those who missed the announcement, what’s the joint venture all about?